BioTools Inc., of Jupiter Florida, and Chiral Technologies Inc., of West Chester, Pennsylvania, have entered into a cooperative agreement that will provide comprehensive coverage of chirality-related services and technologies ranging from small scale and preparative chromatography to absolute configuration of chiral compounds.
BioTools Inc., of Jupiter Florida, and Chiral Technologies Inc., of West Chester, Pennsylvania, have entered into a cooperative agreement that will provide comprehensive coverage of chirality-related services and technologies ranging from small scale and preparative chromatography to absolute configuration of chiral compounds. The combination of services from the two companies is expected to improve efficiency and understanding in a range of research areas such as drug discovery, drug development, and industrial process.
Although the scope of the agreement has not yet been disclosed, Rina Dukor, president of BioTools said “Entering into this collaborative alliance with Chiral Technologies will provide researchers with a unique blend of services, instruments and technologies to advance the understanding that chiral-based structures play in biological and chemical processes.”
BioTools provides advanced chiroptical instrumentation and services to pharmaceutical companies and academia serving critical areas of biopharmaceutical and chiral drugs research. Chiral Technologies supplies chiral chromatography products and services in North and South America.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.